Society of Hematologic Oncology 1st Soho Israel Meeting the 7th International Davidoff Conference 2023

50 $

+ Include: 2 videos + 1 pdf, size: 47.2 GB

+ Target Audience: hematologist, oncologist

Description

+ Include: 2 videos + 1 pdf, size: 47.2 GB

+ Target Audience: hematologist, oncologist

+ Sample video: contact me for sample video

+ Information:

The 1st Soho – Israel Meeting | the 7th International Davidoff Conference

“State of the Art & Next Questions…”

May 3rd –  May 4th 2023, ANU – Museum of the Jewish People, Tel Aviv University

 

An annual International Davidoff Conference has become a tradition for the past 6 years.

SOHO – The Society of Hematologic Oncology was established in 2012 by the MD Anderson Group. Since then, around 6,000 members from 110 countries have joined the society from around the globe.
SOHO’s mission is to expedite worldwide research and education by exchanging scientific information.

Prof. Hagop Kantarjian, chair of the Department of Leukemia at The University of Texas MD Anderson Cancer Center and Prof. Pia Raanani, the ambassador of SOHO to Israel, will launch this year a yearly SOHO – Israel meetings’ program to be merged with the traditional annual Davidoff Conference, entitled: THE 1st SOHO – ISRAEL MEETING & THE 7th INTERNATIONAL DAVIDOFF CONFERENCE – STATE OF THE ART & NEXT QUESTIONS…

The conference is scheduled for May 3th – 5th ,2023 with 2 Educational days at the ANU – Museum of the Jewish People Tel Aviv University, and 1 Round Tables discussions day at the Dan hotel, Tel-Aviv.

The 2023 meeting will focus on new advances and practical clinical applications in the field of hematologic malignancies. The speakers are a multidisciplinary group of internationally recognized experts that represent the spectrum of these diseases.

Alongside the conference, there will be an innovative exhibition of pharmaceutical and medical equipment companies. Guided tours of the ANU museum will be available as well.

As a hybrid event, THE 1st SOHO – ISRAEL MEETING & THE 7th INTERNATIONAL DAVIDOFF CONFERENCE – STATE OF THE ART & NEXT QUESTIONS…offers in-person presence for Israeli participants and virtual attendance options for international attendees.

 

 

+ Topics:

*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below

agenda.pdf
May 3.mp4
May 4.mp4

 

 

  • Detail:

 

May 3rd, 2023

08:00-08:45

08:45-09:30

Registration, Gathering and Exhibition

Opening Ceremony- Honored by the President of the State of Israel
                           His Excellency Mr. Isaac Herzog
                           Honored by the presence of the Davidoff Family

09:30-11:15

Session 1

Chairpersons: Dr. Ofir Wolach & Dr. Itai Levi

09:30-10:00- How I treat ALL at MD Anderson in 2023
                      Hagop Kantarjian, MD, MD Anderson, Houston, USA
10:00-10:05 –  Q&A
10:05-10:40 – Are we ready for risk-adapted therapy in CML 
                    Timothy Hughes, MD, SAHMRI Beat Cancer, University of Adelaide, Australia10:40-11:15 – Novel prediction models in cancer associated thrombosis                      Jeffrey I. Zwicker, MD,Memorial Sloan Kettering Cancer Center, NY, USA

Coffee Break

11:15-11:45

11:45-12:00

Greetings

12:00-13:45

Chairpersons: Dr. Avi Leader & Dr. Tamar Tadmor

12:00-12:35 – Personalized induction strategies for AML                       Gail J. Roboz, MD, Weill Cornell Medicine, The New York Presbyterian Hospital, New York, USA12:35-13:10 – Updates in T cell lymphoma with focus on emerging cellular therapies
                       Swaminathan Padmanabhan Iyer, MD, MD Anderson, Houston, USA13:10-13:45- Present and future of molecular testing in CML                      Simona Soverini, Ph.D, Alma Mater Studiorum Universita di Bologna, Italy

13:45-15:00

Lunch Break & Guided museum tour

15:00-17:20

Session 3

Chairpersons: Dr. Anat Gafter- Gvili & Dr. Luliana Vaxman

15:00-15:35 – Acute lymphoblastic leukemia at a single base resolution                     Gidi Rechavi, MD, Ph.D, Sheba Cancer Research Center, Tel-Hashomer, Israel15:35-16:10 – Moving towards personalized therapy for Hodgkin lymphoma                       Alison Moskowitz, MD, Memorial Sloan Kettering Cancer Center, NY,USA16:10-16:45 – When not to transplant in ALL?                       Elias Joseph Jabbour, MD, MD Anderson, Houston, USA16:45-17:20- Should high risk smoldering myeloma be treated outside of a clinical trial?                       Morie Gertz, MD, Mayo Clinic, Rochester Minnesota, USA

17:20-17:30

Closing Remarks

 

May 4th, 2023

08:00-08:50

Registration, Gathering and Exhibition

08:50-10:45

Session 4

Chairperson: Dr. Tzila Zuckerman & Dr. Avichai Shimoni

08:50-09:00 – Opening Remarks

09:00-09:35 – HMA/VEN…and then?

                     Richard Stone, MD, Dana Farber, Boston, USA

09:35-10:10 – Dormancy as a mechanism of innate resistance to therapy in myeloid malignancies  Michael Deininger, MD, Versiti, USA

10:10-10:45 – Ph+ ALL today

                     Robin Foa, MD, “Sapienza” University of Rome, Italy

10:45-11:15

Coffee Break

11:15-13:00

Session 5

Chairpersons: Dr. Merav Leiba & Dr. Nadav Sarid

11:15-11:50 – From broad to ultra targeted therapeutic approaches in CML: which one is best?

                        Delphine Rea, MD, Hôpital Saint Louis, Paris, France

11:50-12:25 – CML treatment discontinuation in clinical practice: how can we ameliorate its feasibility?

                       Giuseppe Saglio, MD, University of Turin, Italy

12:25-13:00- Lymphoma/cellular therapy

                      Loretta Nastoupil, MD, MD Anderson, Houston, USA

13:00-14:15

Lunch Break & Guided museum tour

14:15-17:20

Session 6

Chairpersons: Dr. Moshe Gatt & Dr. Ariel Aviv

14:15-14:50 – Anticoagulant-related bleeding in Cancer

                      Kristen Sanfilippo, MD, Washington University School of Medicine in St. Louis,USA

14:50-15:25 – T-cell lymphoma

                      Steve Horwitz, MD, Memorial Sloan Kettering Cancer Center NY, USA

15:25-16:00 – Advances and remaining challenges for patients with Follicular Lymphoma

                      Gilles Salles, MD, Memorial Sloan Kettering Cancer Center NY, USA

16:00-17:35 – Novel agents in CLL: better sequenced or combined

                      Jan Burger, MD, MD Anderson, Houston, USA

17:35-18:10 – The changing landscape of artificial intelligence applications in Hematology

                      Roni Shouval, MD, Memorial Sloan Kettering Cancer Center NY, USA

18:10-18:20

Closing Remarks

Reviews

There are no reviews yet.

Be the first to review “Society of Hematologic Oncology 1st Soho Israel Meeting the 7th International Davidoff Conference 2023”

Your email address will not be published. Required fields are marked *